Terry-Ann Burrell
2020
In 2020, Terry-Ann Burrell earned a total compensation of $683.8K as Chief Financial Officer at Beam Therapeutics, a 84% decrease compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $210,000 |
---|---|
Salary | $420,000 |
Other | $53,752 |
Total | $683,752 |
Burrell received $420K in salary, accounting for 61% of the total pay in 2020.
Burrell also received $210K in non-equity incentive plan and $53.8K in other compensation.
Rankings
In 2020, Terry-Ann Burrell's compensation ranked 10,048th out of 13,090 executives tracked by ExecPay. In other words, Burrell earned more than 23.2% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 10,048 out of 13,090 | 23rd |
Division Manufacturing | 4,316 out of 5,624 | 23rd |
Major group Chemicals And Allied Products | 1,776 out of 2,257 | 21st |
Industry group Drugs | 1,554 out of 1,957 | 21st |
Industry Biological Products, Except Diagnostic Substances | 354 out of 411 | 14th |
Source: SEC filing on April 23, 2021.
Burrell's colleagues
We found two more compensation records of executives who worked with Terry-Ann Burrell at Beam Therapeutics in 2020.